Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

Neurology. 2009 May 12;72(19):1708; author reply 1708-9. doi: 10.1212/01.wnl.0000346741.75149.9d.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies
  • Antibody Specificity / immunology
  • Artifacts
  • Biomarkers / analysis
  • Biomarkers / cerebrospinal fluid
  • Humans
  • Immunohistochemistry / methods*
  • Molecular Weight
  • Multiple Sclerosis / cerebrospinal fluid*
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / immunology
  • Myelin Proteins / analysis
  • Myelin Proteins / cerebrospinal fluid*
  • Myelin Proteins / immunology
  • Nogo Proteins
  • Peptide Fragments / cerebrospinal fluid
  • Peptide Fragments / immunology
  • Predictive Value of Tests
  • Reproducibility of Results
  • Staining and Labeling / methods

Substances

  • Antibodies
  • Biomarkers
  • Myelin Proteins
  • Nogo Proteins
  • Peptide Fragments
  • RTN4 protein, human